Author:
Phuyathip Winunya,Putthisen Siyaporn,Panawan Orasa,Ma-In Prasertsri,Teeravirote Karuntarat,Sintusen Phisit,Udomkitkosol Sirintra,Detarya Marutpong,Luang Sukanya,Mahalapbutr Panupong,Sato Takashi,Kuno Atsushi,Chuangchaiya Sriwipa,Silsirivanit Atit
Funder
Graduate School, Kasetsart University
Khon Kaen University
Publisher
Springer Science and Business Media LLC
Reference39 articles.
1. Bojar D, Meche L, Meng G, Eng W, Smith DF, Cummings RD, Mahal LK (2022) A useful guide to lectin binding: machine-learning directed annotation of 57 unique lectin specificities. ACS Chem Biol 17(11):2993–3012. https://doi.org/10.1021/acschembio.1c00689
2. Che MI, Huang J, Hung JS, Lin YC, Huang MJ, Lai HS, Hsu WM, Liang JT, Huang MC (2014) beta1, 4-N-acetylgalactosaminyltransferase III modulates cancer stemness through EGFR signaling pathway in colon cancer cells. Oncotarget 5(11):3673–3684. https://doi.org/10.18632/oncotarget.1981
3. Detarya M, Sawanyawisuth K, Aphivatanasiri C, Chuangchaiya S, Saranaruk P, Sukprasert L, Silsirivanit A, Araki N, Wongkham S, Wongkham C (2020) The O-GalNAcylating enzyme GALNT5 mediates carcinogenesis and progression of cholangiocarcinoma via activation of AKT/ERK signaling. Glycobiology 30(5):312–324. https://doi.org/10.1093/glycob/cwz098
4. Detarya M, Lert-Itthiporn W, Mahalapbutr P, Klaewkla M, Sorin S, Sawanyawisuth K, Silsirivanit A, Seubwai W, Wongkham C, Araki N, Wongkham S (2022) Emerging roles of GALNT5 on promoting EGFR activation in cholangiocarcinoma: a mechanistic insight. Am J Cancer Res 12(9):4140–4159
5. Fedchenko N, Reifenrath J (2014) Different approaches for interpretation and reporting of immunohistochemistry analysis results in the bone tissue - a review. Diagn Pathol 9:221. https://doi.org/10.1186/s13000-014-0221-9